RM
Rippleben Mehta
Head BD and Strategic Alliances
Kemwell Biopharma
About me
Kemwell is looking forward to becoming a leading commercial supplier of biologics to global markets. We have set up internal programs to ensure a successful journey to a Pre-Approval Inspection by the USFDA. Kemwell, since 1980, has successfully worked with various global partners like GSK, Bayer, Merck, and others for their contract services requirement. Now, as a specialized biologics company.
Interested In:
In which geographical areas you plan to expand
North America (USA, Canada)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countries
Is member of
Kemwell Biopharma
Exhibitors
Kemwell Biopharma
Exhibitors
Kemwell Biopharma
Exhibitorsis attending
Keynote Address: Next-Gen Biomanufacturing
Tuesday, October 24, 2023 9:00 AM to 9:15 AM
CPHI Content Hub - CC4.3
Overcoming Challenges in Transferring a Sterile Biologics Drug Product to a CDMO
Tuesday, October 24, 2023 9:15 AM to 9:35 AM
CPHI Content Hub - CC4.3
Olaf Wegener · Siegfried AG
Managing Outsourcing Relationships to Optimise Manufacturing Operations
Tuesday, October 24, 2023 1:30 PM to 1:50 PM
CPHI Content Hub - CC4.3
Biologics Capability and Capacity Expansion Driving Shift to CRDMO Business Models
Tuesday, October 24, 2023 10:05 AM to 10:25 AM
CPHI Content Hub - CC4.3
Building a Collaborative Supply Chain for Biological Products: A Roadmap for the Future
Tuesday, October 24, 2023 9:40 AM to 10:00 AM
CPHI Content Hub - CC4.3